CNBC Cures: Accelerating the Path to Breakthroughs

Written By Greka Lab

We are so excited about the launch of CNBC Cures, a new initiative to raise awareness about genetic disease research, a call to action to deliver better treatments for patients worldwide, and a L2C Accelerator partner and collaborator.

Learn more about the inspiration behind CNBC Cures and its mission here.

Greka Lab
Previous

Connecting genotype and phenotype in CACNA1A-associated disorders
Next

Happy New Year from L2C!